Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Dow Cuts Gains as Pfizer Halves Vaccine Rollout Target on Supply Chain Woes

Stock MarketsDec 03, 2020 04:01PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Yasin Ebrahim

Investing.com - The Dow pared gains into the close on Thursday even as Pfizer halved the number of Covid-19 vaccine doses it plans to ship out this year, denting investor optimism on a faster return to normal for global economies.  

The Dow Jones Industrial Average rose 0.29%, or 86 points, ending the day below the key 30,000 level. The S&P 500 closed flat, while the Nasdaq Composite added 0.23%.

 
Pfizer said it expects to ship half the doses of its Covid-19 vaccine, developed in partnership with BioNTech SE (NASDAQ:BNTX, as raw materials used in early production of the vaccine were not up to standard, the Wall Street Journal reported, citing unknown sources. Pfizer (NYSE:PFE) ended nearly 2% lower.
 
The company said it expects to ship about 50 million doses this year, cooling hopes of a sooner rather than later vaccine widespread rollout that is needed to reopen economies worldwide. 

The negative vaccine news offset a rise in major dow component Boeing (NYSE:BA), up about 6%, after Ryanair placed an order for 75 additional 737 MAX airplanes, increasing its order book to 210 jets.

The Federal Aviation Authority ungrounded Boeing's 737 Max, which was involved in two fatal crashes.

The road to redemption for Boeing 737 Max's will continue as other airlines have pledged to fly the jets again.

American Airlines Group (NASDAQ:AAL) said it will fly the Max jets at the end of the year. Southwest Airlines (NYSE:LUV) will fly the planes in the second quarter.

Sentiment on stocks was also swayed by the latest developments on stimulus. House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell on Thursday discussed a coronavirus relief deal and measures to avoid a government shutdown.
 
Energy enjoyed runaway gains, spurred by surging oil prices after the major produces tapered production cuts by 500,000 barrels per day to 7.2 million barrels a day. It was less than the expected 1.9 million barrels taper expected.

In tech, Snowflake (NYSE:SNOW) jumped 16% after its third-quarter results prompted a slew of upgrades from Wall Street analysts.

"The company continues to execute on the longer-term opportunity, with little to no impact from COVID. We’re impressed by customers’ embracing the broader data cloud platform…" Credit Suisse (SIX:CSGN) said in a note after upgrading its price target on the stock to $265 from $250.

On the economic front, jobless claims fell for the first time in two weeks data. But Jefferies (NYSE:JEF) said the decline this week is "encouraging, but also difficult to trust."

In the week ended Nov. 28, 712,000 people filed for unemployment insurance, down 75,000 from the prior week's upwardly revised 787,000, and lower than the 775,000 claims expected.

In other news, Tesla (NASDAQ:TSLA) jumped 4% after Goldman Sachs (NYSE:GS) hiked its price target on Tesla to $780 from $355 on signs of faster electric vehicles adoption.

Dow Cuts Gains as Pfizer Halves Vaccine Rollout Target on Supply Chain Woes
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (12)
Christopher Cole
Christopher Cole Dec 04, 2020 1:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Crap article old news
beez waxxxxx
beez waxxxxx Dec 03, 2020 6:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this year is almost over ****we begin more next year
Casino Crypt
CasinoCrypt Dec 03, 2020 6:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sounds like there were hiccups in the approval process and cold chain process. Perhaps the news is tempered a bit so as not to spook markets. .. glad I can read between these lines.
James Bell
James Bell Dec 03, 2020 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ruh roh...raw materials used in early production of the vaccine were not up to standard. pretty scary to be first in line for this vaccine!
Thom Miller
Thom Miller Dec 03, 2020 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I agree with you on that! After all, it’s Donny’s vaccine!
Joseph Smeir
Joseph Smeir Dec 03, 2020 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
First in line being the brits
Erski Gumby
SB20 Dec 03, 2020 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thom Miller ok mr wong. LoL
Semih Unalan
Semih Unalan Dec 03, 2020 5:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer always said that it would rollout 50 million doses in 2020 and 1.3 billion doses in 2021. People speculated that maybe it could rollout 100 million and then got disappointed when reports came out that proved pfizer right. Market participants are like kindergardeners.
Thom Miller
Thom Miller Dec 03, 2020 5:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don’t want to say I told you so, but I told you three months ago the heavy lifting was not the development of the vaccines, but the complex logistics of getting it in peoples’ arms. Any President would have been able to get a viable vaccine in less than a year under such trying circumstances. But only someone of President Biden’s caliber can get it distributed properly. That’s just one of many reasons why Donny was shown the door. Perhaps he should leave now before he also screws up the deployment....
James Bell
James Bell Dec 03, 2020 5:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how foolish to think that the president is responsible vaccine distribution, unless of course biden is a manager at pfizer.
Erski Gumby
SB20 Dec 03, 2020 5:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sounds like what David Wong would say. Must be his second kr third account. Thom Wong.
sa Obi
sa Obi Dec 03, 2020 5:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This author need to check his facts. The latest guidance form Pfizer & Biontech was on 20 November 2020 and it stated :   "Based on current projections, the companies expect to produce globally up to 50 million doses in 2020 and up to 1.3 billion doses by the end of 2021; the companies will be ready to distribute the vaccine within hours after authorization" https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-submit-emergency-use-authorization-request https://investors.pfizer.com/investor-news/press-release-details/2020/Pfizer-and-BioNTech-to-Submit-Emergency-Use-Authorization-Request-Today-to-the-U.S.-FDA-for-COVID-19-Vaccine/default.aspx The 100mil was initial estimates and the 20 November guidance surely could not have any effect on the DOW or Nasdaq or S&P. He just repeats the narrative of the WSJ without checking the facts and then blame a historic guidance for todays moves in the market. Spreading misinformation.
Fernando Lazarini
Fernando Lazarini Dec 03, 2020 4:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great time to resuscitate the "vaccine hopes wanes" headline .
Francesco Lucchesi
Francesco Lucchesi Dec 03, 2020 4:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
oh dear really ? are there issues? the first of many such type of statements
Ridha B younes
Ridha B younes Dec 03, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
does all these news impacr gold / silver price YES always in the negative impact anything to suppress the price of gold .Not for long .
Ridha B younes
Ridha B younes Dec 03, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
return of gold bull by this morning
Ammar Gasim
Ammar Gasim Dec 03, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I can see gold to continue dropping until there is a potential war, otherwise nope
Alan West
Alan West Dec 03, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gold isnt being suppressed. Its a myth. It’s going a lot lower too.
Francesco Lucchesi
Francesco Lucchesi Dec 03, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alan West ahahahah gold is going to skyrocket to 3000
Kel dawg
Kel dawg Dec 03, 2020 4:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seriously why do people freak out on this? it is common sense that there will be supplies issue since have 7 billion + on the planet. do the peopple just magically think vaccine will just pop out in mass within weeks...
Laura Blumberg
Laura Blumberg Dec 03, 2020 4:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next vaccine will be approved on dec 17th then watch Pfizer get some news out then. The Democratic party had players in these fields playing games with out lives. Maybe time for Republicans to pull all federal funding to Pfizer
Matt Kay
Matt Kay Dec 03, 2020 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oh noes! Not my vaccine hopes!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email